[New Year's Message] Lee Dong-hoon, CEO of SK Biopharm, "Rejump as a Global Healthcare Company"
Lee Dong-hoon, President of SK Biopharm, announced the New Year's goal at the New Year's meeting held on the 2nd to transform the company into the only differentiated global healthcare company in Korea through organizational innovation and the growth of employees. (Photo by SK Biopharm)
View original image[Asia Economy Reporter Lee Chun-hee] On the 2nd, at the New Year's meeting, Lee Dong-hoon, CEO of SK Biopharm, announced the vision, stating, "It is time for organizational and individual change and innovation to achieve greater success in the global market," and "We will leap forward as the only differentiated global healthcare company in Korea."
Lee Dong-hoon, who has led global new drug business development and bio investments at the SK Bio Investment Center, was appointed as the new CEO of SK Biopharm and its U.S. subsidiary SK Life Sciences on November 30 last year, and officially took office on the 1st.
At the New Year's meeting held with about 200 executives and employees, CEO Lee emphasized, "SK Biopharm has achieved success not only in Korea but also in the U.S. and European pharmaceutical markets," and "Now is the time for organizational and individual change and innovation to achieve greater success in the global market." He continued, "We must quickly address the shortcomings of the organization and each member, accurately identify the necessary capabilities, and demonstrate them," adding, "To foster organizational growth, we will maximize sales of 'cenobamate,' secure next-generation pipelines, and actively communicate to promote the development and expertise of our executives and employees."
CEO Lee stated, "This year, we aim to catch these two rabbits simultaneously, achieving growth for both the organization and its members," and pledged, "SK Biopharm will soon leap forward as the only differentiated global healthcare company in Korea with future growth technology pipelines and innovative talent, significantly contributing not only to enhancing corporate value but also to national economic and social development."
Hot Picks Today
'Still Hesitant? If You're Wondering Whether KOSPI Will Rise, This Is the Number You Must Watch [Weekend Money]'
- About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- Is It Really Like an Illness? "I Can't Wait to Go Again"—Over 1 Million Visited in Q1, Now 'Busanbyeong' Takes Hold [K-Holic]
This New Year's meeting broke away from the traditional format and was held in a movie theater to foster harmony in a fresh and unique atmosphere. Before the movie screening, programs such as a lottery event were held, allowing all executives and employees to participate and enjoy.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.